Invited Commentary: Prostatic Artery Embolization Versus Transurethral Resection of the Prostate: A Post Hoc Cost Analysis of a Randomized Controlled Clinical Trial, By Capdevila et al
- PMID: 34561741
- DOI: 10.1007/s00270-021-02972-5
Invited Commentary: Prostatic Artery Embolization Versus Transurethral Resection of the Prostate: A Post Hoc Cost Analysis of a Randomized Controlled Clinical Trial, By Capdevila et al
Comment on
-
Prostatic Artery Embolization Versus Transurethral Resection of the Prostate: A Post Hoc Cost Analysis of a Randomized Controlled Clinical Trial.Cardiovasc Intervent Radiol. 2021 Nov;44(11):1771-1777. doi: 10.1007/s00270-021-02920-3. Epub 2021 Jul 20. Cardiovasc Intervent Radiol. 2021. PMID: 34286370 Free PMC article. Clinical Trial.
References
-
- Capdevila F, Insausti I, Galbete A, Sanchez-Iriso E, Mantesino M. Prostatic artery embolization versus transurethral resection of the prostate: a post hoc cost analysis of a randomized controlled clinical trial. Cardiovasc Intervent Radiol. 2021. https://doi.org/10.1007/s00270-021-02920-3 ((published online 20 July 2021; accessed 8 August 2021)). - DOI - PubMed
-
- Insausti I, de Ocariz AS, Galbete A, et al. Randomized comparison of prostatic artery embolization berus transurethral resection of the prostate for treatment of benign prostatic hyperplasia. J Vasc Intervent Radiol. 2020;31:882–90. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
